Clinical Trials Directory

Trials / Completed

CompletedNCT05403398

BSCU1 and Immune Function

Change in Markers of Immune Function Associated With Bacillus Subtilis CU1 Intervention in Different Age Groups

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
89 (actual)
Sponsor
Lesaffre International · Industry
Sex
All
Age
3 Years – 79 Years
Healthy volunteers
Accepted

Summary

The current study aims to explore a range of possible pathways by which BSCU1 could beneficially modulate the immune system, in three target populations representing the general population.

Detailed description

This exploratory study is designed as a single-arm study with repeated measures, involving three different populations, in which each subject serves as its own control. The duration of the intervention is 4 weeks, with biomarker assessments at baseline, after 2 weeks, and after 4 weeks intervention.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTB. subtilis CU12 billion CFUs daily, for 4 weeks

Timeline

Start date
2022-06-07
Primary completion
2022-10-18
Completion
2023-03-20
First posted
2022-06-03
Last updated
2024-01-08

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT05403398. Inclusion in this directory is not an endorsement.